Similarly, we observed that Mapk13 knockout mice exhibited much lower levels of ALT and AST in serum (Fig. 5f), less liver fibrosis area (Fig. 5g) and fewer dead cells (Fig. 5h) in liver tissues in DDC-treated mice. The gene discussed is MAPK13; the disease is Hepatic fibrosis.